“…The enzymes derived from PFKFB1, PFKFB2 and PFKFB4 were originally found to be expressed by cells of the liver/muscle, kidney/heart and testes, respectively, and all display nearly equal kinase: phosphatase ratios (Okar and Lange, 1999). The PFKFB3 gene encodes for the inducible PFK2/FBPase (Chesney et al, 1999;Atsumi et al, 2002;Mahlknecht et al, 2003), which is rapidly induced by inflammatory stimuli (Chesney et al, 1999) and hypoxia (Minchenko et al, 2002;Minchenko et al, 2004) and has also been termed placental PFK2 (Sakai et al, 1996;Sakakibara et al, 1999), ubiquitous PFK2 (Manzano et al, 1998;Kessler and Eschrich, 2001;Navarro-Sabate et al, 2001) and PGR1 (Hamilton et al, 1997)). The PFKFB3 protein product was recently documented to be overexpressed in the neoplastic cells of human solid tumors, including lung, breast, prostate and colon tumors and to display minimal phosphatase activity (kinase:phosphatase ratio 740:1), suggesting a constitutively pro-glycolytic activity (Sakakibara et al, 1997;Chesney et al, 1999;Chesney and Bucala, 2001;Atsumi et al, 2002).…”